Prediction of pathological activity in Crohn’s disease based on dual-energy CT enterography
Abdominal Radiology · 10.04.2024 · 49 (6) · 1829-1838
DOI: 10.1007/s00261-024-04276-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, online erschienen am 10.04.2024. Verfasst von Hai-Fei Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Affiliated Huai'an NO.1 People's Hospital of Nanjing Medical University, 1# Huanghe West Road, Huaiyin District, Huai'an…. Hauptthemen laut MEDLINE: Crohn Disease, Tomography, X-Ray Computed, Radiography, Dual-Energy Scanned Projection, Contrast Media. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To explore the feasibility of predicting the pathological activity of Crohn’s disease (CD) based on dual-energy CT enterography (DECTE).
Methods
The clinical, endoscopic, imaging and pathological data of 55 patients with CD scanned by DECTE were retrospectively analyzed; the pathological results were used as a reference standard to classify the diseased bowel segments into active and inactive phases. The normalized iodine concentration (NIC), energy-spectrum curve slope K, dual energy index (DEI), fat fraction (FF) of the arterial phases and venous phases were compared. To assess the parameters’ predictive ability, receiver-operating characteristic curves were used. The Delong test was used to compare the differences between the diagnostic efficiency of each parameter.
Results
A total of 84 intestinal segments were included in the study, including 54 active intestinal segments and 30 inactive intestinal segments. The NIC, energy-spectrum curve slope K and DEI were significantly different between active and inactive bowel segments in the arterial and venous phases ( P < 0.05), while FF were not significantly different ( P > 0.05). The largest area under the curve (AUC) of NIC, energy-spectrum curve slope K and DEI were higher in arterial phase than in venous phase. For identifying the intestinal activity of CD, the maximum AUC of NIC in arterial phase was 0.908, with a sensitivity of 0.833 and a specificity of 0.800, and the DEI in arterial phase had the highest sensitivity (0.944).
Conclusion
The NIC, energy-spectrum curve slope K and DEI can effectively distinguish the active and inactive phases of the intestinal segments of CD patients and provide good assistance for determining further treatment. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The Affiliated Huai'an NO.1 People's Hospital of Nanjing Medical University, 1# Huanghe West Road, Huaiyin District, Huai'an, 223300, Jiangsu Province, China.
- Department of Pathology, The Affiliated Huai'an NO.1 People's Hospital of Nanjing Medical University, 1# Huanghe West Road, Huaiyin District, Huai'an, 223300, Jiangsu Province, China.
- Department of Radiology, The Affiliated Huai'an NO.1 People's Hospital of Nanjing Medical University, 1# Huanghe West Road, Huaiyin District, Huai'an, 223300, Jiangsu Province, China. guolili163@163.com.
ORCID-Profile: Li-Li Guo
Zitieren
APA
Zhou, H. F., Chen, W., Li, J. Q., Bai, G. J., & Guo, L. L. (2024). Prediction of pathological activity in Crohn’s disease based on dual-energy CT enterography. Abdominal Radiology, 49(6), 1829-1838. https://doi.org/10.1007/s00261-024-04276-x
Vancouver
Zhou HF, Chen W, Li JQ, Bai GJ, Guo LL. Prediction of pathological activity in Crohn’s disease based on dual-energy CT enterography. Abdominal Radiology. 2024;49(6):1829-1838. doi:10.1007/s00261-024-04276-x
BibTeX
@article{Zhou2024,
author = {Zhou, Hai-Fei and Chen, Wei and Li, Jing-Qi and Bai, Gen-Ji and Guo, Li-Li},
title = {Prediction of pathological activity in Crohn’s disease based on dual-energy CT enterography},
journal = {Abdominal Radiology},
year = {2024},
volume = {49},
number = {6},
pages = {1829--1838},
doi = {10.1007/s00261-024-04276-x}
}
EUVIMED